`lhttp://www.effectivedesign.org.uk/grand prix/solostar.php
`◄ 27 ►
`7~ c~a_w_u-re-s- - ---"-----"' --"----=' - - - - ' - ' - - - - - - - - - - - - - - - - - - '
`
`27 Oct 2009 - 3 Apr 2011
`
`2008 2009 2011
`
`,, About this capture
`
`AWARD CATEGORIES
`
`[;::The Grand Prix
`
`The Grand Prix
`
`Corporate/Brand Identity
`
`Packaging
`
`Design for Society
`
`Museums, Galleries, Events
`& Visitor Attractions
`
`Product
`
`Design Management
`
`Environment
`
`Interactive & Digital Media
`
`Internal Communications
`
`Point of Sale
`
`
`SOLOSTAR DISPOSABLE PEN
`INJECTOR
`
`MORE WINNERS
`
`AGENCY: DCA Design International
`CLIENT: Sanofi Aventis GmbH
`
`Pen injectors were introduced over 20 years ago to deliver liquid medication to
`patients. Lanius, a new once-a-day insulin, was originally offered in a licensed
`injector device, but in 2003, in order to sustain development of the new insulin,
`Sanofi Aventis decided to develop its own injector.
`
`DCA Design International were tasked with designing a new injector that would
`deliver a single dose of 80 insulin units without causing discomfort or
`inconvenience. It also had to satisfy industry standards. Focusing strongly on the
`needs of users, DCA Design International created a new operating mechanism to
`deliver a low injection force and a subtle yet appealing design. They also used
`colour and other differentiation features to help improve safety.
`
`SoloSTAR successfully met all product requirements and outperformed previous
`devices in terms of comfort, safety and ease-of-use. 7 out of 10 patients now
`prefer the lower injection force of SoloSTAR to competitor products and in 2008 it
`accounted for 41 % of all growth in the global injectable insulin market.
`
`View all Product awards
`
`Download PDF
`
`CAN YOU HELP US?
`
`SITEMAP
`
`PRIVACY POLICY
`
`PRESS
`
`CONTACT US
`
`Design Business Association - 35-39 Old Street - London EC1 V 9HX
`T +44 (0)20 7251 9229 - F +44 (0)20 7251 9221
`
`Sanofi Exhibit 2122.001
`Mylan v. Sanofi
`IPR2018-01675
`
`